Caspera is a pharmaceutical company that develops treatments for rare diseases. The company was founded in 2019 by a team of experienced biotech executives, and is headquartered in Cambridge, Massachusetts. Caspera's lead drug candidate is currently in clinical trials for the treatment of a rare genetic disorder. The company is focused on developing treatments for diseases that have few or no treatment options. Caspera has received funding from several venture capital firms, including Flagship Pioneering.